$54.95 $1.83 per serving
Product analysis
LFG Burn Razzle Dazzle uses caffeine to support short-term alertness and exercise performance. The complex mixtures have unknown proportions, making some added ingredients harder to compare.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality33
Several ingredient sources are named, but that does not confirm the quality of the full performance mixture. Missing forms and mixture proportions leave the preparation less clearly characterized.
Ingredient Transparency71
All listed amounts and most ingredient forms are disclosed. Unknown proportions within the caffeine, sodium and botanical mixtures prevent a complete composition comparison.
Value For Money27
Caffeine, Alpha-GPC and huperzine offer poor value at the serving price. Value for many remaining ingredients is uncertain, so the long list does not establish a cost advantage.
Customer Satisfaction73
Ratings are positive, but the small number of reviews limits confidence. A small pool of opinions cannot establish a typical experience or health benefit.
Product Focus33
Caffeine provides the clearest immediate contribution to alertness and exercise. The 300 mg serving may add jitteriness or anxiety, while a single serving does not reproduce weeks of beta-alanine use.
- Format
Powder - Container
- 11 Ounce(s)
- Per serving
- $1.83
- Customer rating
- 4.9 · 12 ratings
Goals
Impact
High effect
Beta-Alanine · 3200 mgCaffeine · 300 mg
Beta-Alanine Not classified
No linked studies yet.
Impact
High effect
Caffeine · 300 mg
Impact
High effect
Huperzine · 200 mcgAlpha-GPC · 200 mgCaffeine · 300 mg
Impact
Highest effect
Caffeine · 300 mg
Beta-Alanine Not classified
No linked studies yet.
Impact
High effect
Alpha-GPC · 200 mgCaffeine · 300 mgHuperzine · 200 mcg
Huperzine Not classified
No linked studies yet.
Impact
High effect
Huperzine · 200 mcgAlpha-GPC · 200 mg
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Sodium (Himalayan Rock Salt, Sodium Citrate) | 80 mg | |
Beta-Alanine | 3200 mg | |
Nitrosigine (Inositol-Stabilized Arginine Silicate) | 1500 mg | |
Caffeine (Caffeine Anhydrous, Caffeine Anhydrous, Microencapsulated) | 300 mg | |
MitoBurn (Beta-Aminoisobutyric Acid) | 250 mg | |
AlphaSize Alpha GPC | 200 mg | |
Mucuna pruriens extract (L-Dopa) | 100 mg | |
AstraGin (Astragalus membranaceous, Panax notoginseng) | 25 mg | |
Paradoxine (Grains of Paradise) | 10 mg | |
Huperzine A | 200 mcg |
The serving contains 300 mg of caffeine, a high amount. The cost per serving is very high. The caffeine source is unspecified in the available information.
How this ingredient is rated
Active Ingredient Quality & Bioavailability40
The caffeine source is unspecified in the available information.
Advanced Bioavailability and Release Profiles
The caffeine source is unspecified in the available information.
Dose, Safety & Label Transparency92
The serving contains 300 mg of caffeine, a high amount. No additional stimulants are recorded in the available information.
Caffeine Dose Transparency
The total caffeine amount is stated as 300 mg per serving.
Dosage Efficacy and Safety Margin
The serving contains 300 mg of caffeine, a high amount.
Secondary Stimulant Disclosure and Risk
No additional stimulants are recorded in the available information.
Value10
The cost per serving is very high.
Price Per Serving vs. Collection Median
The cost per serving is very high.
Huperzine · 200 mcg OverallScore47
The serving supplies 200 mcg of Huperzine A, an amount associated with cognitive focus, at a high cost for the amount. Huperzine A is named, but its plant source and extract details are unspecified. Cycling guidance is not available in the recorded information.
How this ingredient is rated
Active Ingredient Quality & Bioavailability20
Huperzine A is named, but its plant source and extract details are unspecified.
Source and Standardization Clarity
The Huperzine A source and extract details are not specified.
Dose, Safety & Label Transparency88
The serving provides 200 mcg of Huperzine A, an amount associated with cognitive focus. No cycling instructions are available in the recorded information.
Huperzine A Dosage Efficacy
200 mcg of Huperzine A per serving is within the amount associated with cognitive focus.
Cycling Guidance and Transparency
The Huperzine A amount is stated, but cycling guidance is not available.
Value20
The cost of the product relative to its Huperzine A amount is high.
Price per 100mcg of Huperzine A
At the product price, the cost per 100 mcg of Huperzine A is high.
Alpha-GPC · 200 mg OverallScore67
The serving provides 200 mg of Alpha-GPC, with a very high cost for the amount. AlphaSize is a branded form of Alpha-GPC. The active amount is stated, but a separate yield is not.
How this ingredient is rated
Active Ingredient Quality & Bioavailability100
AlphaSize is a branded form of Alpha-GPC.
Patented/Branded Form and Source
AlphaSize is a branded form of Alpha-GPC.
Dose, Safety & Label Transparency62
A serving provides 200 mg of Alpha-GPC. A separate active-yield statement is not available.
Active Alpha-GPC Dosage
The stated active Alpha-GPC amount is 200 mg per serving.
Label Transparency & Yield Disclosure
The active amount is stated, but a separate active-yield statement is not available.
Value10
The cost for the stated Alpha-GPC amount is very high.
Price per 300mg Active Alpha-GPC
The cost per 300 mg of Alpha-GPC is very high.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis.
- Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized controlled and open-label observation trial.
- Effects of choline alfoscerate on cognitive function and quality of life in type 2 diabetes: A double-blind, randomized, placebo-controlled trial.
- Acute Alpha-Glycerylphosphorylcholine Supplementation Enhances Cognitive Performance in Healthy Men.
- Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial.
- Huperzine a in the treatment of Alzheimer's disease and vascular dementia: a meta-analysis.
- [Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial].
- Huperzine A associated with improved early postoperative cognitive function after neurosurgery under general anesthesia: a randomized clinical trial.
- Treatment with Huperzine A improves cognition in vascular dementia patients.
- Huperzine-A response to cognitive impairment and task switching deficits in patients with Alzheimer's disease.
- [Gliatilin in the Treatment of Cognitive Impairments Not Reaching the Level of Dementia: Meta-Analysis and Systematic Review].
- Vertical Association Between Dietary Total Choline and L-alpha-glycerylphosphorylcholine and the Cognitive Function in Chinese Adults Aged over 55, Result from China Health and Nutrition Survey 1997-2018.
- Adjunctive huperzine A for cognitive deficits in schizophrenia: a systematic review and meta-analysis.
- [Drug evaluation of huperzine A in the treatment of senile memory disorders].
- Cognitive and mood improvements of caffeine in habitual consumers and habitual non-consumers of caffeine.
- Caffeine-containing energy drink improves physical performance of elite rugby players during a simulated match.
- Differential cognitive effects of energy drink ingredients: caffeine, taurine, and glucose.
- Does Single or Combined Caffeine and Taurine Supplementation Improve Athletic and Cognitive Performance without Affecting Fatigue Level in Elite Boxers? A Double-Blind, Placebo-Controlled Study.
- Trait Energy and Fatigue Modify the Effects of Caffeine on Mood, Cognitive and Fine-Motor Task Performance: A Post-Hoc Study.
- The effect of L-arginine supplementation on maximal oxygen uptake: A systematic review and meta-analysis.